Moreover, the presence of other driver mutations in ccRCC, such as VHL or PBRM1, often co‐mutated with SETD2, would complicate interpretation of SETD2‐specific contributions to EMT. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.